PRESS RELEASE published on 01/09/2025 at 09:00, 1 year 4 months ago Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency FDA Biotest AG Fibrinogen Biologics License Application Medical Treatment
BRIEF published on 11/15/2024 at 09:05, 1 year 6 months ago Minister and Mayor Advocate for Plasma Donations at Biotest's Center Biotest AG Public Awareness Plasma Donations Darmstadt Healthcare Employment
BRIEF published on 11/15/2024 at 09:05, 1 year 6 months ago Le ministre et le maire plaident en faveur des dons de plasma au centre Biotest Biotest AG Sensibilisation Du Public Darmstadt Dons De Plasma Emploi Dans Le Secteur De La Santé
PRESS RELEASE published on 11/15/2024 at 09:00, 1 year 6 months ago Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses Community Support Healthcare Biotest AG Plasma Donations Plasma Center
BRIEF published on 11/14/2024 at 10:19, 1 year 6 months ago Biotest Reports 4.5% Revenue Increase in First Nine Months of 2024 Financial Outlook Biotest Revenue Yimmugo® Growth Fibrinogen BT524 Grifols Agreement
BRIEF published on 11/14/2024 at 10:19, 1 year 6 months ago Biotest annonce une augmentation de son chiffre d'affaires de 4,5 % au cours des neuf premiers mois de 2024 Perspectives Financières Chiffre D'affaires De Biotest Croissance De Yimmugo® Fibrinogène BT524 Accord Grifols
PRESS RELEASE published on 11/14/2024 at 10:14, 1 year 6 months ago Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted Revenue Growth EBIT Biotest AG Product Sales Marketing Authorization
BRIEF published on 11/14/2024 at 09:01, 1 year 6 months ago Biotest AG Revises Revenue, Cash Flow, and ROCE Forecasts for 2024 Revenue Growth Financial Forecast Biotest AG ROCE EBIT Guidance
BRIEF published on 11/14/2024 at 09:01, 1 year 6 months ago Biotest AG révise ses prévisions de revenus, de flux de trésorerie et de ROCE pour 2024 Biotest AG ROCE Prévisions Financières Croissance Des Revenus Prévisions EBIT
PRESS RELEASE published on 11/14/2024 at 08:56, 1 year 6 months ago EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged Biotest AG corrects forecast for revenue, cash flow, and ROCE while maintaining EBIT guidance. Details on the adjustments made for the 2024 financial year disclosed Revenue Cash Flow Biotest AG ROCE Forecast Correction
Published on 05/22/2026 at 14:04, 16 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 20 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 20 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 20 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 14:00, 20 minutes ago EQ Inc. Reports First Quarter 2026 Financial Results and Annual General Meeting Results
Published on 05/22/2026 at 14:00, 20 minutes ago Helvetia Baloise Annual General Meeting approves all proposals of the Board of Directors
Published on 05/22/2026 at 14:00, 20 minutes ago Verve Group Publishes Agenda for its Upcoming Capital Markets Day 2026 in New York
Published on 05/22/2026 at 13:56, 23 minutes ago Form 8.3 - Advanced Medical Sol Group PLC - Opening Position Disclosure
Published on 05/22/2026 at 13:15, 1 hour 5 minutes ago MINISO Opens First Swiss Store, Introducing Its Signature IP-Driven Retail Experience to Bern
Published on 05/22/2026 at 13:15, 1 hour 5 minutes ago Gravity Game Unite's Ragnarok Zero: Global OBT Is Now Live, with Global User Participation Heating Up!
Published on 05/22/2026 at 12:52, 1 hour 27 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 hour 27 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 5 hours 50 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 5 hours 50 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc